Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α

Oh,Yoon  Suk; Kim,Ha  Yon; Song,Ik-Chan; Yun,Hwan-Jung; Jo,Deog-Yeon; Kim,Samyong; Lee,Hyo  Jin

doi:10.3892/or.2012.2063

Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α

Authors:
- Yoon Suk Oh
- Ha Yon Kim
- Ik-Chan Song
- Hwan-Jung Yun
- Deog-Yeon Jo
- Samyong Kim
- Hyo Jin Lee
View Affiliations

Affiliations: Department of Internal Medicine and Cancer Research Institute, Chungnam National University School of Medicine, Daejeon 301-131, Republic of Korea
Published online on: September 27, 2012 https://doi.org/10.3892/or.2012.2063
Pages: 2239-2246

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Given the important role of CXCR4 in cancer metastasis, microenvironmental factors that modulate CXCR4 may have an impact on the process of tumor expansion. Hypoxia is a common feature of solid tumors and a significant microenvironmental factor that drives aggressive behavior. CXCR4 is upregulated in several cancer cells under hypoxic conditions, suggesting a relationship between tumor hypoxia and CXCR4. However, the role of hypoxia in regulating CXCR4 in gastric cancer remains poorly understood. KATO III gastric cancer cells were exposed to hypoxia or normoxia. CXCR4 expression in cells transfected with shRNA specific for HIF-1α was investigated by western blotting and flow cytometry. Wound healing, migration and invasion assays were used to assess cell motility and the chemotactic response to CXCL12, a major CXCR4 ligand. CXCR4 expression at the protein level and in the cell membrane was significantly increased in KATO III cells following exposure to hypoxia. This upregulation of CXCR4 was implicated in increased cell motility and enhanced chemotactic responses (migration and invasion) to CXCL12 treatment in vitro. The increases in CXCR4 expression and metastatic potential in gastric cancer cells exposed to hypoxia were blocked by HIF-1α-specific shRNA. Our results indicate that hypoxia upregulates CXCR4 in gastric cancer cells in a HIF-1α-dependent manner, and that upregulation of CXCR4 plays a role in cancer cell migration and invasion. Thus, disrupting the hypoxia-HIF-1α-CXCR4 axis could be an attractive therapeutic strategy for the treatment of gastric cancer.

View Figures

View References

1	Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 24:2137–2150. 2006. View Article : Google Scholar
2	Lee HJ, Cho do Y, Park JC, et al: Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer. Cancer Chemother Pharmacol. 63:427–432. 2009. View Article : Google Scholar : PubMed/NCBI
3	Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y and Lin KH: Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol. 22:2267–2276. 2011. View Article : Google Scholar : PubMed/NCBI
4	Lee HJ, Huang SM, Kim HY, et al: Evaluation of the combined expression of chemokine SDF-1 alpha and its receptor CXCR4 as a prognostic marker for gastric cancer. Exp Ther Med. 2:499–504. 2011.PubMed/NCBI
5	Shen Z, Seppanen H, Vainionpaa S, et al: IL10, IL11, IL18 are differently expressed in CD14(+) TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxia. Cytokine. 59:352–357. 2012.PubMed/NCBI
6	Song IC, Liang ZL, Lee JC, et al: Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer. Oncol Lett. 2:1197–1202. 2011.
7	Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z and Andreeff M: CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood. 113:1504–1512. 2009. View Article : Google Scholar : PubMed/NCBI
8	Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
9	Richard CL, Tan EY and Blay J: Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha. Int J Cancer. 119:2044–2053. 2006. View Article : Google Scholar : PubMed/NCBI
10	Sun X, Cheng G, Hao M, et al: CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
11	Wang Y, Li Z, Zhang H, et al: HIF-1alpha and HIF-2alpha correlate with migration and invasion in gastric cancer. Cancer Biol Ther. 10:376–382. 2010. View Article : Google Scholar : PubMed/NCBI
12	Wang X, Li C, Chen Y, et al: Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun. 371:283–288. 2008. View Article : Google Scholar : PubMed/NCBI
13	Schioppa T, Uranchimeg B, Saccani A, et al: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
14	Krishnamachary B, Berg-Dixon S, Kelly B, et al: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63:1138–1143. 2003.PubMed/NCBI
15	Ishikawa T, Nakashiro K, Klosek SK, et al: Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep. 21:707–712. 2009.PubMed/NCBI
16	Cronin PA, Wang JH and Redmond HP: Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer. 10:2252010. View Article : Google Scholar : PubMed/NCBI
17	Schutyser E, Su Y, Yu Y, et al: Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw. 18:59–70. 2007.PubMed/NCBI
18	Lee HJ, Lee K, Lee DG, et al: Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Clin Cancer Res. 18:3270–3280. 2012. View Article : Google Scholar : PubMed/NCBI
19	Kwak MK, Hur K, Park DJ, et al: Expression of chemokine receptors in human gastric cancer. Tumour Biol. 26:65–70. 2005. View Article : Google Scholar : PubMed/NCBI
20	Yasumoto K, Koizumi K, Kawashima A, et al: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 66:2181–2187. 2006. View Article : Google Scholar : PubMed/NCBI
21	Lee HJ, Kim SW, Kim HY, et al: Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol. 34:473–480. 2009.PubMed/NCBI
22	Pituch-Noworolska A, Drabik G, Szatanek R, et al: Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer. Pol J Pathol. 58:93–97. 2007.PubMed/NCBI
23	Sun XJ, Sun KL, Zheng ZH, et al: Gene expression patterns in gastric cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 23:142–146. 2006.PubMed/NCBI
24	Hashimoto I, Koizumi K, Tatematsu M, et al: Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer. 44:1022–1029. 2008. View Article : Google Scholar : PubMed/NCBI
25	Tsuboi K, Kodera Y, Nakanishi H, et al: Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep. 20:1117–1123. 2008.PubMed/NCBI
26	Iwasa S, Yanagawa T, Fan J and Katoh R: Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res. 29:4751–4758. 2009.PubMed/NCBI
27	Arigami T, Natsugoe S, Uenosono Y, et al: CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009. View Article : Google Scholar : PubMed/NCBI
28	Zhao BC, Wang ZJ, Mao WZ, et al: CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol. 17:2389–2396. 2011. View Article : Google Scholar : PubMed/NCBI
29	Ding YL, Zhang JL, Tang SF, Fu QY and Li ZT: Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer. Zhonghua Yi Xue Za Zhi. 88:202–205. 2008.(In Chinese).
30	Koizumi K, Kato S, Sakurai H, Hashimoto I, Yasumoto K and Saiki I: Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer. Front Biosci (Schol Ed). 4:269–276. 2012. View Article : Google Scholar : PubMed/NCBI
31	Noda S, Yashiro M, Nshii T and Hirakawa K: Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Eur J Cancer. 46:995–1005. 2010. View Article : Google Scholar : PubMed/NCBI
32	Hockel M, Schlenger K, Hockel S and Vaupel P: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res. 59:4525–4528. 1999.PubMed/NCBI
33	Zhong H, De Marzo AM, Laughner E, et al: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:5830–5835. 1999.PubMed/NCBI
34	Hynes RO: Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell. 113:821–823. 2003. View Article : Google Scholar : PubMed/NCBI
35	Griffiths EA, Pritchard SA, Welch IM, Price PM and West CM: Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer. 41:2792–2805. 2005. View Article : Google Scholar : PubMed/NCBI
36	Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509–4515. 1996.PubMed/NCBI
37	Generali D, Berruti A, Brizzi MP, et al: Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res. 12:4562–4568. 2006. View Article : Google Scholar
38	Bachtiary B, Schindl M, Potter R, et al: Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res. 9:2234–2240. 2003.
39	Schindl M, Schoppmann SF, Samonigg H, et al: Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 8:1831–1837. 2002.PubMed/NCBI
40	Pan J, Mestas J, Burdick MD, et al: Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer. 5:562006. View Article : Google Scholar : PubMed/NCBI
41	Phillips RJ, Mestas J, Gharaee-Kermani M, et al: Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem. 280:22473–22481. 2005.
42	Shim H, Lau SK, Devi S, Yoon Y, Cho HT and Liang Z: Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. Biochem Biophys Res Commun. 346:252–258. 2006. View Article : Google Scholar : PubMed/NCBI
43	Kim SW, Kim HY, Lee HJ, Yun HJ, Kim S and Jo DY: Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells. Leuk Lymphoma. 50:1163–1173. 2009. View Article : Google Scholar : PubMed/NCBI
44	Sun X, Wei L, Chen Q and Terek RM: CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression. Mol Cancer. 9:172010. View Article : Google Scholar : PubMed/NCBI
45	Dunn LK, Mohammad KS, Fournier PG, et al: Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PloS One. 4:e68962009. View Article : Google Scholar : PubMed/NCBI
46	Zagzag D, Lukyanov Y, Lan L, et al: Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest. 86:1221–1232. 2006. View Article : Google Scholar : PubMed/NCBI
47	Mahaseth H and Kaufman J: Optimizing stem cell collection through CXCR4 antagonists. Front Biosci (Schol Ed). 4:611–619. 2012.PubMed/NCBI
48	Gangadhar T, Nandi S and Salgia R: The role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther. 9:409–416. 2010. View Article : Google Scholar : PubMed/NCBI
49	Iwanaga T, Iwasaki Y, Ohashi M, Nunobe S and Iwagami S: Establishment of a CXCR4-expressing gastric cancer cell line in nude mice and the effect of AMD 3100 on tumor regression. Gan To Sagaku Ryoho. 34:1917–1919. 2007.(In Japanese).